ICL Historical Balance Sheet
ICL Stock | USD 4.63 0.01 0.22% |
Trend analysis of ICL Israel Chemicals balance sheet accounts such as Other Current Liabilities of 507.2 M or Total Current Liabilities of 1.9 B provides information on ICL Israel's total assets, liabilities, and equity, which is the actual value of ICL Israel Chemicals to its prevalent stockholders. By breaking down trends over time using ICL Israel balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining ICL Israel Chemicals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ICL Israel Chemicals is a good buy for the upcoming year.
ICL Israel Inventory |
|
ICL |
About ICL Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of ICL Israel Chemicals at a specified time, usually calculated after every quarter, six months, or one year. ICL Israel Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ICL Israel and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ICL currently owns. An asset can also be divided into two categories, current and non-current.
ICL Israel Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of ICL Israel assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ICL Israel Chemicals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on ICL Israel balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ICL Israel Chemicals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from ICL Israel's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, ICL Israel's Intangible Assets are quite stable compared to the past year. Long Term Debt is expected to rise to about 2.3 B this year, although the value of Short and Long Term Debt Total will most likely fall to about 2.2 B.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 3.0B | 2.8B | 2.7B | 2.2B | Total Assets | 11.1B | 11.8B | 11.6B | 7.7B |
ICL Israel balance sheet Correlations
Click cells to compare fundamentals
ICL Israel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ICL Israel balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.2B | 9.7B | 11.1B | 11.8B | 11.6B | 7.7B | |
Short Long Term Debt Total | 2.6B | 2.8B | 3.0B | 2.8B | 2.7B | 2.2B | |
Other Current Liab | 587M | 654M | 755M | 970M | 692.4M | 507.2M | |
Total Current Liabilities | 1.8B | 2.2B | 2.6B | 2.6B | 2.6B | 1.9B | |
Total Stockholder Equity | 3.9B | 3.9B | 4.5B | 5.5B | 5.8B | 3.1B | |
Property Plant And Equipment Net | 5.2B | 5.6B | 5.8B | 6.0B | 6.3B | 3.7B | |
Net Debt | 2.5B | 2.6B | 2.5B | 2.4B | 2.3B | 2.0B | |
Retained Earnings | 3.9B | 3.8B | 4.3B | 5.4B | 5.6B | 5.9B | |
Accounts Payable | 712M | 740M | 1.1B | 1.0B | 912M | 633.8M | |
Cash | 95M | 214M | 473M | 417M | 420M | 441M | |
Non Current Assets Total | 6.5B | 6.8B | 7.2B | 7.2B | 7.6B | 4.8B | |
Non Currrent Assets Other | 353M | 393M | 279.8M | 228M | 379M | 236.1M | |
Cash And Short Term Investments | 191M | 314M | 564M | 508M | 592M | 325.7M | |
Net Receivables | 1.2B | 883M | 1.4B | 1.8B | 1.4B | 1.2B | |
Good Will | 302M | 320M | 502M | 507M | 530M | 266.3M | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.4B | |
Short Term Investments | 92M | 96M | 100M | 91M | 172M | 127.5M | |
Liabilities And Stockholders Equity | 9.2B | 9.7B | 11.1B | 11.8B | 11.6B | 7.7B | |
Non Current Liabilities Total | 3.4B | 3.4B | 3.7B | 3.4B | 3.0B | 2.6B | |
Inventory | 1.3B | 1.3B | 1.6B | 2.1B | 1.7B | 1.3B | |
Other Current Assets | 51M | 275M | 357M | 323M | 363M | 381.2M | |
Other Stockholder Equity | (62M) | (56M) | (36M) | (27M) | (26M) | (24.7M) | |
Total Liab | 5.1B | 5.6B | 6.3B | 6.0B | 5.6B | 4.5B | |
Property Plant And Equipment Gross | 5.3B | 5.6B | 12.5B | 13.0B | 13.8B | 14.5B | |
Total Current Assets | 2.7B | 2.8B | 3.9B | 4.5B | 4.0B | 2.9B | |
Accumulated Other Comprehensive Income | (439M) | (312M) | (306M) | (443M) | (338M) | (354.9M) | |
Short Term Debt | 420M | 679M | 577M | 580M | 865M | 540.8M | |
Current Deferred Revenue | 42M | 17M | 33M | 41M | 10M | 9.5M | |
Intangible Assets | 332M | 336M | 365M | 345M | 343M | 403.7M | |
Other Liab | 1.2B | 1.3B | 1.3B | 1.1B | 1.3B | 1.1B | |
Other Assets | 362M | 309M | 378M | 524M | 434.7M | 384.2M | |
Long Term Debt | 2.2B | 2.1B | 2.4B | 2.3B | 1.6B | 2.3B | |
Property Plant Equipment | 5.3B | 5.6B | 5.8B | 6.0B | 6.9B | 5.1B | |
Net Tangible Assets | 3.3B | 3.3B | 3.7B | 4.6B | 5.3B | 3.1B | |
Long Term Investments | 140M | 83M | 26M | 3M | 2M | 1.9M | |
Short Long Term Debt | 371M | 684M | 577M | 512M | 786M | 523.7M | |
Long Term Debt Total | 1.8B | 2.2B | 2.1B | 2.4B | 2.2B | 1.9B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Dividend Share 0.2 | Earnings Share 0.31 | Revenue Per Share 5.373 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.